Crinetics Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Crinetics Pharmaceuticals stock has a consensus rating of "Hold" and an average price target of $82.5. The average 1-year stock price forecast is 1.61% lower than the current stock price, while the lowest is $55 (-34.41%) and the highest is $90 (+7.33%).

Price Target: $82.5 (-1.61%)

Analyst Consensus: Hold

Price Target

Chart

Target	Low	Average	Median	High
Price	$55	$82.5	$85	$90
Change	-34.41%	-1.61%	+1.37%	+7.33%

Analyst Ratings

The average analyst rating for Crinetics Pharmaceuticals stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

Chart

Rating	Feb '26	Mar '26	Apr '26	May '26	Jun '26	Jul '26
Strong Buy	12	12	12	12	12	2
Buy	3	3	3	3	3	0
Hold	1	1	1	1	1	12
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	16	16	16	16	16	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kate Dellorusso LifeSci Capital	LifeSci Capital	Hold Maintains $85	Hold	Maintains	$85	+1.37%	Jul 11, 2026
Alex Thompson CFA Stifel Nicolaus	Stifel Nicolaus	Hold Downgrades $83 → $85	Hold	Downgrades	$83 → $85	+1.37%	Jul 8, 2026
Gavin Clark-Gartner Evercore ISI	Evercore ISI	Hold Downgrades $88 → $85	Hold	Downgrades	$88 → $85	+1.37%	Jul 8, 2026
Tyler Van Buren TD Cowen	TD Cowen	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jul 7, 2026
Jonathan Wolleben Citizens JMP	Citizens JMP	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jul 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

68.49M

from 7.70M

789.97%

from 7.70M

Revenue Next Year

172.19M

from 68.49M

151.40%

from 68.49M

EPS This Year

-4.62

from -4.95

EPS Next Year

-4.07

from -4.62

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.08M	4.74M	4.01M	1.04M	7.70M	68.49M
Revenue Growth	1,418.31%	339.43%	-15.28%	-74.11%	640.71%	789.97%
Operating Income	-107.70M	-167.88M	-222.61M	-338.85M	-516.77M	-538.84M
Net Income	-107.64M	-163.92M	-214.53M	-298.41M	-465.32M	-516.49M
EPS	-	-	-	-	-4.95	-4.62
Free Cash Flow	-48.47M	-62.51M	-93.53M	-136.41M	-206.91M	-417.67M
No. Analysts	-	-	-	-	-	13

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	76.1M
Avg	68.5M
Low	57.7M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	888.6%
Avg	790.0%
Low	650.2%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.48
Avg	-4.62
Low	-5.28

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-